Gemina Laboratories (XCNQ:GLAB) Market Cap : C$32.83 Mil (As of May. 27, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Gemina Laboratories's share price for the quarter that ended in Oct. 2023 was C$0.47. Gemina Laboratories's Shares Outstanding (EOP) for the quarter that ended in Oct. 2023 was 73.33 Mil. Therefore, Gemina Laboratories's market cap for the quarter that ended in Oct. 2023 was C$34.46 Mil.

Gemina Laboratories's quarterly market cap declined from Apr. 2023 (C$45.46 Mil) to Jul. 2023 (C$36.66 Mil) and declined from Jul. 2023 (C$36.66 Mil) to Oct. 2023 (C$34.46 Mil).

Gemina Laboratories's annual market cap increased from Jan. 2021 (C$0.00 Mil) to Jan. 2022 (C$27.80 Mil) and increased from Jan. 2022 (C$27.80 Mil) to Jan. 2023 (C$46.10 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Gemina Laboratories's Enterprise Value for Today is C$33.33 Mil.

Gemina Laboratories Market Cap Historical Data

The historical data trend for Gemina Laboratories's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Market Cap Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

Market Cap

27.80

46.10

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Market Cap	Get a 7-Day Free Trial						28.84	46.10	45.46	36.66	34.46

Competitive Comparison of Gemina Laboratories's Market Cap

For the Biotechnology subindustry, Gemina Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gemina Laboratories's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Market Cap distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Market Cap falls into.

Gemina Laboratories Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Gemina Laboratories's Market Cap for the fiscal year that ended in Jan. 2023 is calculated as

Market Cap (A: Jan. 2023 )	=	Share Price (A: Jan. 2023 )	*	Shares Outstanding (EOP) (A: Jan. 2023 )
	=	C$0.7	*	65.8529
	=	C$46.10

Gemina Laboratories's Market Cap for the quarter that ended in Oct. 2023 is calculated as

Market Cap (Q: Oct. 2023 )	=	Share Price (Q: Oct. 2023 )	*	Shares Outstanding (EOP) (Q: Oct. 2023 )
	=	C$0.47	*	73.3259
	=	C$34.46

Gemina Laboratories (XCNQ:GLAB) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Gemina Laboratories Market Cap Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

GLABF:USA 8I7:Germany

Address

3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website

https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines